This systematic review underscores the dual oncogenic and tumor-suppressive roles of SP100 family proteins (SP100, SP110, SP140, SP140L) across 25 cancer types, shaped by context-dependent expression patterns, genetic/epigenetic alterations, and possible interactions with tumor microenvironments. The gene discussed is SP100; the disease is neoplasm.